In late September 2020, eight drug companies voluntarily complied with a request made by the U.S. Food and Drug Administration (FDA) on May 28, 2020, to recall certain metformin products from the ...

In May 2020, the Food and Drug Administration (FDA) recommended that some makers of metformin extended release remove some of their tablets from the U.S. market. This is because an unacceptable ...

Glipizide/metformin HCl; 2.5mg/250mg, 2.5mg/500mg, 5mg/500mg; tabs. Adjunct to diet and exercise in type 2 diabetes, as initial therapy or as second-line therapy when response to a sulfonylurea or ...

for two lots of Pioglitazone And Metformin Hydrochloride tablets," the USFDA said. Both the recalls by the companies are class III recalls, it added. As per the USFDA, a class III recall is ...

Saxagliptin, metformin HCl (ext-rel); 5mg/500mg, 5mg/1000mg, 2.5mg/1000mg; tabs. Saxagliptin is a competitive DPP4 inhibitor that slows the inactivation of the incretin hormones, thereby ...